(Reuters) - Walgreen, one of the largest U.S. drugstore chains, has typically grown on its own rather than through acquisitions, but has been acquiring assets to expand its lineup of health-related services. Walgreen's latest move comes months after its main rival, CVS, became the largest provider of specialty pharmacy services with its acquisition of Caremark.
Walgreen expects the acquisition to close in a few months and add "slightly" to earnings in the first year and more in future years, Chief Financial Officer William Rudolphsen said during a conference call. He also said Walgreen anticipates pretax synergies of about $15 million in the first year.
Read more at Reuters.com Market News
Walgreen expects the acquisition to close in a few months and add "slightly" to earnings in the first year and more in future years, Chief Financial Officer William Rudolphsen said during a conference call. He also said Walgreen anticipates pretax synergies of about $15 million in the first year.
Read more at Reuters.com Market News
No comments:
Post a Comment